Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia

Leukemia

Volumn 7, Issue 8, 1993, Pages 1225-1231

  Fioretos, Thoas ^a,b   Nilsson, Per Gunnar ^b   Aman, Pierre ^a   Heim, Sverre ^a,c   Kristoffersson, Ulf ^a   Malm, Claes ^d   Simonsson, Bengt ^e   Turesson, Ingemar ^b   Mitelman, Felix ^a  

^a Department of Clinical Genetics ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Regional Hospital ^*  (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CHROMOSOME BREAKAGE; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; FEMALE; GENE MAPPING; HEMATOLOGY; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RNA SPLICING; SCHOOL CHILD; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHILD; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FUSION PROTEINS, BCR-ABL; HUMAN; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGE; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA SPLICING; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE;

EID: 0027236472     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Silver RT. Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase. Hematol Oncol Clin North Am 1990;4:319-355.
2. Sokal JE, Baccarani M, Russo D, Tura S. Staging and prognosis in chronic myelogenous leukemia. Semin Hematol 1988;25:49-61.
3. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med 1990;88:1-8.
4. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 244:290-293.
5. Heim S, Mitelman F. Multistep cytogenetic scenario in chronic myeloid leukemia. Adv Viral Oncol 1987;7:53-76.
6. Heisterkamp N, Groffen J. Molecular insights into the Philadelphia translocation. Hematol Pathol 1991;5:1-10.
7. Dreazen O, Canaani E, Gale RP. Molecular biology of chronic myelogenous leukemia. Semin Hematol 1988; 25:35-49.
8. Kurzrock R, Talpaz M. The molecular pathology of chronic myelogenous leukaemia. Br J Haematol 1991;79, Suppl. 1:34-37.
9. Schaefer-Rego K, Dudek H, Popenoe D, Arlin Z, Mears JG, Bank A, Leibowitz D. CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood 1987;70:448-455.
10. Bernards A, Rubin CM, Westbrook CA, Paskind M, Baltimore D. The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocation in chronic myelogenous leukemia. Mol Cell Biol 1987;7:3231-3236.
11. Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985;315:550-554.
12. Grosveld G, Verwoerd T, van Agthoven T, De Klein A, Ramachandran KL, Heisterkamp N, Stam K, Groffen J. The chronic myelocytic cell line K562 contains a break-point in bcr and produces a chimeric bcr/abl transcript. Mol Cell Biol 1981;6:607-616.
13. Ben-Neriah Y, Daley GQ, Mes-Masson A, Witte ON, Baltimore D. The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science 1986;233:212-214.
14. Mills KI, Benn P, Birnie GD. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991;78:1155-1161.
15. Simonsson B, Öberg G, Björeman M, Björkhohn M, Gahrton G, Hast R, Killander A, Turesson I, Uden A-M, Vikrot O, Vilen L, Wahlin A, Carneskog J, Westlin J. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia. Leuk Lymphoma 1992;7 (Suppl.):55-57.
16. 1-positive childhood chronic myeloid leukemia. Leukemia 1992;6:723-725.
17. ISCN (1991) F. Mitelman, ed. Guidelines for Cancer Cytogenetics, supplement to An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1991.
18. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
19. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-1995.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
21. Maurer J, Janssen JWG, Thiel E, Van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D, Bartram CR. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991;337:1055-1058.
22. Hehlmann R, Heimpel H, Griesshammer M, Kolb HJ, Heinze B, Hossfeld DK, Wickramanayake PD, Essers U, Thiele J, Georgii A, Ansari H, Hochhaus A, Hasford J, and the German CML Study Group. Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. Leukemia 1992;6 (Suppl. 3): 110S-114S.
23. Shtalrid M, Talpaz M, Kurzrock R, Kantarjian H, Trujillo J, Gutterman J, Yoffe G, Blick M. Analysis of break-points within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood 1988;72:485-490.
24. Jaubert J, Martiat P, Dowding C, Ifrah N, Goldman JM. The position of the M-bcr breakpoint does not predict the duration of chronic phase or survival on chronic myeloid leukaemia. Br J Haematol 1990;74:30-35.
25. Morris SW, Daniel L, Ahmed CMI, Elias A, Lebowitz P. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Blood 1990;75:2035-2041.
26. Tefferi A, Bren GD, Wagner KV, Schaid DJ, Ash RC, Thibodeau SN. The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia 1990;4:839-842.
27. Opalka B, Wandl U, Beer U, Roggenbuck U, Kloke O, Niedele N. Breakpoint localization within the M-bcr and the clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa Interferon therapy. Leukemia 1991;5:452-456.
28. Inokuchi K, Futaki M, Yamada T, Tanabe Y, Dan K, Shinohara T, Kuriya S-H, Nomura T. The relationship between the site of breakpoints within the BCR gene and thrombopoiesis of Philadplphia-positive chronic myelocytic leukemia. Leuk Res 1991;15:1067-1073.
29. Mills KI, MacKenzie ED, Birnie GD. The site of break-point within the bcr is a prognostic factor in Philadelphia-positive CML patients. Blood 1988;72:1237-1241.
30. Eisenberg A, Silver R, Soper L, Arlin Z, Coleman M, Bernhardt B, Benn P. The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Leukemia 1988;2:642-647.
31. Mills KI, Hynds SA, Burnett AK, MacKenzie ED, Birnie GD. Further evidence that the site of the breakpoint in the major breakpoint (M-bcr) may be a prognostic indicator. Leukemia 1989;3:837-840.
32. Grossman A, Silver RT, Arlin Z, Coleman M, Camposano, E, Gascon P, Benn PA. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia. Am J Hum Genet 1989;45:729-738.
33. Mills KI, Sproul AM, Leibowitz D, Burnett AK. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene. Leukemia 1991;5:937-941.
34. Tanaka K, Kamada N. bcr gene rearrangement and expression in chronic myelocytic leukemia. Acta Haematol Jpn 1990;53:1559-1568.
35. Przepiorka D. Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis. Cancer Genet Cytogenet 1988;36: 117-122.
36. Tien HF, Wang CH, Chen YC, Shen MC, Wu HS, Lee FY, Chuang SM, Liu CH. Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease. Br J Haematol 1990;75:469-475.
37. Hernandez JM, Gonzalez-Sarmiento R, Martin C, Gonzalez M, Sanchez I, Corral J, Orfao A, Canizo MC, San Miguel JF, Lopez-Borrasca A. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia. Br J Haematol 1991;79:408-414.
38. Martinelli G, Chiamenti A, Gasparini P, Pignatti PF, Ambrosetti A. BCR breakpoint subregions and blast crisis lineage in CML patients. Blood 1992;79:838-839.
39. Marcelle C, Gale RP, Prokocimer M, Berrebi A, Merle-Beral H, Canaani E. Analysis of BCR-ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR-related sequence in human DNA. Genes Chrom Cancer 1989;1:172-179.
40. Morgan GJ, Hernandez A, Chan LC, Hughes T, Martiat P, Wiedeman LM. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia. Br J Haematol 1990;76:33-38.
41. Dubé I, Dixon J, Beckett T, Grossman A, Weinstein M, Benn P, McKeithan T, Norman C, Pinkerton P. Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes. Genes Chrom Cancer 1989; 1:106-111.
42. Nishigaki H, Inazawa J, Miswa S, Nishida K, Okuda T, Horiike S, Tsuda S, Taniwaki M, Abe T. Distribution of breakpoint within the breakpoint cluster region (bcr) in chronic myelogenous leukemia with a complex Philadelphia chromosome translocation. Am J Hematol 1989;32:194-199.
43. Zaccaria A, Testoni N, Tassinari A, Celso B, Rassool F, Saglio G, Guerrasio A, Rosti G, Tura S. Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations. Cancer Genet Cytogenet 1989;42:191-201.
44. 1-positive CML. Leuk Res 1991;15:999-1003.
45. Nakamura K, Miyashita T, Ozaki M, Iwaya M, Nakazawa S, Okamura J, Kamada N, Tanaka K, Kobayashi N, Mizutani S. Molecular studies of chronic myelogenous leukemia using the polymerase chain reaction. Cancer 1991;68:2426-2430.